Quick Takeaways
- Alessandro Riva has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $14,085,358.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Alessandro Riva
- Location
- Philadelphia, PA
- Summary
- The estimated net worth of Alessandro Riva is at least $14,085,358 dollars as of 06 Jan 2026. Alessandro Riva is the Director of BeiGene, Ltd. and owns shares of BeOne Medicines Ltd. (ONC) stock worth about $13.94M. Alessandro Riva is the Director of BICYCLE THERAPEUTICS PLC and owns shares of BICYCLE THERAPEUTICS PLC (BCYC) stock worth about $140.8K.
- Signature
- /s/ Travis Thompson, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Alessandro Riva and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: BeiGene, Ltd. ($13,944,606).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Alessandro Riva
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ONC, BEIGF | BeiGene, Ltd. | Director | $13,944,606 | 21 May 2025 | ||
| BCYC | BICYCLE THERAPEUTICS PLC | Director | $140,752 | 02 Jan 2026 | ||
| IPSC | Century Therapeutics, Inc. | Director | 12 Jun 2025 |
Insider Transactions Reported by Alessandro Riva:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.